Asco 2025 · Posters ·
Tumores del Sistema Nervioso Central
Asco 2025 · Posters ·
Tumores del Sistema Nervioso Central
Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Preliminary results of phase Ib/II CAN-201 NDG trial.